"Despite being widely performed in clinical practice, pulmonary vein isolation ablation has never been compared with a sham procedure," said principal investigator Dr. Rick Veasey. "Our results ...

There are worries about delayed complications, but many places won’t get paid if AF patients don’t spend the night in ...

Patients in the group receiving regular ablation underwent pulmonary vein isolation (PVI) alone or PVI plus anatomical ablation, whereas those in the aggressive treatment group underwent PVI ...

The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

The upper pulmonary ... at a smaller risk of ablation induced PV stenosis. Therefore, the authors believe that published data clearly challenge the established view that isolation of all four ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection ... be that it's just another pulmonary vein isolation (PVI) add-on that ...

Johnson & Johnson MedTech (NYSE: JNJ) announced 12-month data from its SmartfIRE clinical trial of the ThermoCool SmartTouch ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

A control group of 59 patients will receive the standard pulmonary vein isolation ablation procedure, while a study group of 118 patients will receive a pulmonary vein isolation procedure by ...

Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists in assessing complex cardiac arrhythmias such as atrial ...

"Clinical data has also shown that the Volt catheter's cutting-edge design helps physicians achieve pulmonary vein isolation in fewer ablation attempts and less therapy applications for improved ...